HeXun Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Feb '25 Feb 20, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,482	2,981	-	-
Enterprise Value	3,238	2,763	-	-
Last Close Price	75.70	64.80	-	-
PE Ratio	28.07	89.01	-	-
PS Ratio	14.74	22.83	-	-
PB Ratio	6.32	6.30	-	-
P/TBV Ratio	6.58	6.79	-	-
P/FCF Ratio	115.06	132.95	-	-
P/OCF Ratio	51.29	69.18	-	-
EV/Sales Ratio	13.70	21.16	-	-
EV/EBITDA Ratio	23.61	64.08	-	-
EV/EBIT Ratio	27.85	100.94	-	-
EV/FCF Ratio	107.00	123.24	-	-
Debt / Equity Ratio	0.06	0.15	0.23	0.35
Debt / EBITDA Ratio	0.25	1.56	13.75	-
Debt / FCF Ratio	1.12	3.24	7.16	-
Asset Turnover	0.42	0.27	0.14	-
Quick Ratio	12.11	11.67	9.82	10.87
Current Ratio	12.69	12.05	10.55	11.94
Return on Equity (ROE)	25.43%	8.50%	-1.96%	-
Return on Assets (ROA)	12.81%	3.51%	-1.61%	-
Return on Capital (ROIC)	13.38%	3.67%	-1.66%	-
Return on Capital Employed (ROCE)	19.97%	5.06%	-	-
Earnings Yield	3.57%	1.12%	-	-
FCF Yield	0.87%	0.75%	-	-
Buyback Yield / Dilution	-10.22%	-20.81%	-22.92%	-
Total Shareholder Return	-10.22%	-20.81%	-22.92%	-

Source: S&P Capital IQ. Standard template. Financial Sources.